Cargando…
Cutaneous lupus erythematosus disease assessment: Highlighting CLE outcome measures
Autores principales: | Gaffney, Rebecca G., Werth, Victoria P., Merola, Joseph F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9614355/ https://www.ncbi.nlm.nih.gov/pubmed/36314023 http://dx.doi.org/10.3389/fmed.2022.968469 |
Ejemplares similares
-
Emerging Therapies in Cutaneous Lupus Erythematosus
por: Sprow, Grant, et al.
Publicado: (2022) -
Proteome study of cutaneous lupus erythematosus (CLE) and dermatomyositis skin lesions reveals IL-16 is differentially upregulated in CLE
por: Niewold, Timothy B., et al.
Publicado: (2021) -
Pathophysiology of cutaneous lupus erythematosus
por: Achtman, Jordan C, et al.
Publicado: (2015) -
Comparing dermatologic patient-reported outcome measures in cutaneous lupus erythematosus
por: Sprow, Grant, et al.
Publicado: (2022) -
Subacute cutaneous lupus erythematosus and systemic lupus erythematosus associated with abatacept
por: Tarazi, Meera, et al.
Publicado: (2018)